. Step 33 of 41
Clinical Stem 3
A patient with right upper lobe adenocarcinoma progressing on biomarker-directed therapy

Question 9
At this point, what would you do?
A. Defer molecular testing to the treating oncologist

B. Defer molecular testing to the pathologist

C. Order the tests based on the previous discussions with the oncologist and the pathologist

D. Do not order any tests until after lung cancer tissue acquisition, handling and processing are streamlined at your institution
incorrect correct